Embolism
Not yet recruitingA study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.
A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.
- Disease:Embolism
- Substances:Human Igg4 S228P Monoclonal Antibody Against Factor Xi And Activated Factor Xi
France- Participants:18–64 years · 65+ years
- Substances:Human Igg4 S228P Monoclonal Antibody Against Factor Xi And Activated Factor Xi
- Sponsor:Regeneron Pharmaceuticals Inc.








